We are live on ! Find out more
IMGN

Immunogen Inc

Delisted

IMGN was delisted on the 9th of February, 2024.

131 hedge funds and large institutions have $423M invested in Immunogen Inc in 2014 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 50 increasing their positions, 37 reducing their positions, and 30 closing their positions.

New
Increased
Maintained
Reduced
Closed

179% more call options, than puts

Call options by funds: $11.2M | Put options by funds: $4.03M

35% more repeat investments, than reductions

Existing positions increased: 50 | Existing positions reduced: 37

7% less funds holding

Funds holding: 141131 (-10)

30% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 30

47% less capital invested

Capital invested by funds: $795M → $423M (-$372M)

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

Holders
131
Holders Change
-10
Holders Change %
-7.09%
% of All Funds
3.49%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
21
Increased
50
Reduced
37
Closed
30
Calls
$11.2M
Puts
$4.03M
Net Calls
+$7.2M
Net Calls Change
+$2.39M
Name Holding Trade Value Shares
Change
Change in
Stake
EWM
151
Evercore Wealth Management
New York
-$106K -10,000 Closed
Ameriprise
152
Ameriprise
Minnesota
-$68K -6,415 Closed
Federated Hermes
153
Federated Hermes
Pennsylvania
-$51K -4,831 Closed
NFG
154
Next Financial Group
Texas
-$32K -3,000 Closed
PTC
155
Private Trust Company
Ohio
-$4K -360 Closed
WA
156
Waverly Advisors
Alabama
-$2K -161 Closed
JFA
157
JNBA Financial Advisors
Minnesota
-$1K -117 Closed
FANJ
158
Financial Architects (New Jersey)
New Jersey
-$1K -83 Closed

IMGN Hedge Fund Activity: Q4 2014 in Review

131 of the 3,749 institutional investors tracked by Wall St. Rank reported a position in Immunogen Inc (IMGN) for Q4 2014, worth a combined $423M — down 47% from $795M a quarter earlier.

Sellers outnumbered buyers: 30 funds closed out of IMGN and 21 opened new positions — a net loss of 9 holders — while 37 trimmed existing stakes and 50 added.

The largest buyer was Millennium Management, adding an estimated $12.3M. The largest seller was First Trust Advisors, exiting entirely with an estimated $61.5M sold.

  • 131 institutional investors held Immunogen Inc (IMGN) as of Q4 2014, down from 141 in Q3 2014.
  • Funds reported $423M of Immunogen Inc stock for Q4 2014, down 47% quarter-over-quarter.
  • 21 funds opened new Immunogen Inc positions in Q4 2014 and 30 closed out, a net change of -9 holders.
  • The largest Immunogen Inc buyer in Q4 2014 was Millennium Management, an estimated $12.3M added.
  • The largest Immunogen Inc seller in Q4 2014 was First Trust Advisors, an estimated $61.5M sold.

Based on aggregated 13F filings for Q4 2014.